21.01.2011 • NewsSüd-ChemieClariantDick Cashin

Big Guns Chase Süd-Chemie Majority Stake

Four companies have been named as potential bidders in a majority stake of Süd...
Four companies have been named as potential bidders in a majority stake of Süd Chemie. Will it come to a showdown? (Photo ©Randy Pertiet/flickr)

One Equity Partners (OEP) has lined up at least four bidders for its majority stake in Germany's Süd-Chemie, putting other investors under pressure to sell, people briefed on the matter told Reuters.

U.S. conglomerate Honeywell, Belgian catalysts and battery-materials maker Umicore, the Japanese maker of Verbatim data disks Mitsubishi Chemical and Swiss chemicals group Clariant are among the prospective buyers, three sources close to the suitors said late on Wednesday.

A spokesman for OEP, which holds 50.41% of Süd-Chemie, reiterated that the private-equity firm was looking into strategic options for Süd-Chemie, including a stake sale.

Süd-Chemie, a maker of catalysts and absorbants, declined to comment, while a Mitsubishi Chemical spokesman said he had not heard of the matter and the other possible bidders declined to comment.

A potential conflict could be brewing over Süd-Chemie because the bidders would prefer to take over the entire company and fold it into their operations to cut costs, while some long-term minority shareholders are reluctant to part with their stakes, the sources told Reuters.

Key shareholders are chemical-industry heir and entrepreneur Dolf Stockhausen with 10.2%, the Winterstein family with 10.1%, and Axel Schweighard, a descendant of one of the group's founders, with 3.39%.

None could be reached for immediate comment.

With €1.2 billion ($1.6 billion) in expected 2010 sales, up 10% year-on-year, Süd-Chemie has a market value of about 1.5 billion euros. However, it has a free float of less than 26%.

The shares, which change hands only sporadically, trade at 13.1 times annual core earnings, including net debt, about 20% above the average of its five closest peers, according to Thomson Reuters StarMine.

Süd-Chemie, founded in 1857, is mainly coveted for its catalysts business, which caters to the sprawling petrochemical industry in the Middle East, including SABIC.

The division, which competes with Denmark's unlisted Haldor Topsoe, makes compounds that speed up or enable chemical reactions and its catalysts also help turn plant material into biofuel.

Süd-Chemie's second division, which makes absorbents for detergents and paper and which are also used to refine olive oil, is regarded as less attractive.

OEP, headed by U.S. investment banker Dick Cashin, bought a stake in Süd-Chemie in 2005 for 35 euros per share and in 2007 obtained a majority holding.

Company

Süd-Chemie

Lenbachplatz 6
80333 München
Germany

Company contact







Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

Interview

Fostering Innovation and Collaboration
Specialty Chemicals Distributor IMCD’s Strategy

Fostering Innovation and Collaboration

Valerie Diele-Braun, CEO of IMCD, shares her vision for sustainability, global expansions, and strategic direction in an exclusive CHEManager International interview.

most read

Photo
19.03.2025 • NewsInnovation

Data-Driven Enzyme Immobilization

Inseit, based in Bern, develops biocatalysts for industrial setups using enzyme immobilization and biocomputation. Addressing biotech and sustainability challenges, Inseit was selected for Venture Leaders Biotech and won two Nucleate accelerator prizes.

Photo
24.01.2025 • News

And the Winners are: Cynio, EnaDyne and Green Li-ion

The CHEManager Innovation Pitch, the start-up promotion initiative of CHEManager and CHEManager International, has given more than 100 start-ups from over 15 countries the opportunity to present their innovative ideas, products and technologies to a broad target group since its launch in 2019.

Photo
27.03.2025 • News

J&J to Invest $55 Billion in US Operations

US healthcare giant Johnson & Johnson (J&J) has unveiled plans to invest over $55 billion in the US over the next four years. This significant investment marks a 25% increase compared to the previous four years, the company said.